Wikidata

(Q42278640)

English

A phase II trial of cardioprotection with Cardioxane (ICRF-187) in patients with advanced breast cancer receiving 5-fluorouracil, doxorubicin and cyclophosphamide

scientific article published on May 1995

In more languages

Statements

title
A phase II trial of cardioprotection with Cardioxane (ICRF-187) in patients with advanced breast cancer receiving 5-fluorouracil, doxorubicin and cyclophosphamide (English)
1 reference
stated in
Europe PubMed Central
PubMed ID
7715910
retrieved
19 October 2017
author name string
Kolaric K
series ordinal
1
1 reference
stated in
Europe PubMed Central
PubMed ID
7715910
retrieved
19 October 2017
Bradamante V
series ordinal
2
1 reference
stated in
Europe PubMed Central
PubMed ID
7715910
retrieved
19 October 2017
Cervek J
series ordinal
3
1 reference
stated in
Europe PubMed Central
PubMed ID
7715910
retrieved
19 October 2017
Cieslinska A
series ordinal
4
1 reference
stated in
Europe PubMed Central
PubMed ID
7715910
retrieved
19 October 2017
Cisarz-Filipcak E
series ordinal
5
1 reference
stated in
Europe PubMed Central
PubMed ID
7715910
retrieved
19 October 2017
Denisov LE
series ordinal
6
1 reference
stated in
Europe PubMed Central
PubMed ID
7715910
retrieved
19 October 2017
Drosik K
series ordinal
8
1 reference
stated in
Europe PubMed Central
PubMed ID
7715910
retrieved
19 October 2017
Gershanovic M
series ordinal
9
1 reference
stated in
Europe PubMed Central
PubMed ID
7715910
retrieved
19 October 2017
Hudziec P
series ordinal
10
1 reference
stated in
Europe PubMed Central
PubMed ID
7715910
retrieved
19 October 2017
page(s)
251-255
1 reference
stated in
Europe PubMed Central
PubMed ID
7715910
retrieved
19 October 2017

Identifiers

DOI
10.1159/000227467
0 references
 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q42278640&oldid=1940953500"